These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 9109106)

  • 1. Fluoxetine in the treatment of premenstrual dysphoria.
    Su TP; Schmidt PJ; Danaceau MA; Tobin MB; Rosenstein DL; Murphy DL; Rubinow DR
    Neuropsychopharmacology; 1997 May; 16(5):346-56. PubMed ID: 9109106
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Weekly luteal-phase dosing with enteric-coated fluoxetine 90 mg in premenstrual dysphoric disorder: a randomized, double-blind, placebo-controlled clinical trial.
    Miner C; Brown E; McCray S; Gonzales J; Wohlreich M
    Clin Ther; 2002 Mar; 24(3):417-33. PubMed ID: 11952025
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of menstrual cycle phase on neuroendocrine and behavioral responses to the serotonin agonist m-chlorophenylpiperazine in women with premenstrual syndrome and controls.
    Su TP; Schmidt PJ; Danaceau M; Murphy DL; Rubinow DR
    J Clin Endocrinol Metab; 1997 Apr; 82(4):1220-8. PubMed ID: 9100599
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fluoxetine in the treatment of premenstrual dysphoria. Canadian Fluoxetine/Premenstrual Dysphoria Collaborative Study Group.
    Steiner M; Steinberg S; Stewart D; Carter D; Berger C; Reid R; Grover D; Streiner D
    N Engl J Med; 1995 Jun; 332(23):1529-34. PubMed ID: 7739706
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The role of fluoxetine in the treatment of premenstrual dysphoric disorder.
    Romano S; Judge R; Dillon J; Shuler C; Sundell K
    Clin Ther; 1999 Apr; 21(4):615-33; discussion 613. PubMed ID: 10363729
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Treatment of premenstrual syndrome with fluoxetine: a double-blind, placebo-controlled, crossover study.
    Wood SH; Mortola JF; Chan YF; Moossazadeh F; Yen SS
    Obstet Gynecol; 1992 Sep; 80(3 Pt 1):339-44. PubMed ID: 1495689
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fluoxetine improves functional work capacity in women with premenstrual dysphoric disorder.
    Steiner M; Brown E; Trzepacz P; Dillon J; Berger C; Carter D; Reid R; Stewart D
    Arch Womens Ment Health; 2003 Feb; 6(1):71-7. PubMed ID: 12715267
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of fluoxetine, bupropion, and placebo in the treatment of premenstrual dysphoric disorder.
    Pearlstein TB; Stone AB; Lund SA; Scheft H; Zlotnick C; Brown WA
    J Clin Psychopharmacol; 1997 Aug; 17(4):261-6. PubMed ID: 9241004
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fluoxetine in the treatment of premenstrual syndrome.
    Stone AB; Pearlstein TB; Brown WA
    Psychopharmacol Bull; 1990; 26(3):331-5. PubMed ID: 2274633
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fluoxetine in the treatment of late luteal phase dysphoric disorder.
    Stone AB; Pearlstein TB; Brown WA
    J Clin Psychiatry; 1991 Jul; 52(7):290-3. PubMed ID: 2071558
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Assessment of sexual drive and desire in women with premenstrual dysphoric disorder who have been treated with fluoxetine.
    Steiner M; MacDougall M; Berger C; Carter D; Reid R; Steinberg S; Stewart D
    Int J Psychiatry Clin Pract; 2005; 9(2):120-3. PubMed ID: 24930793
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fluoxetine's spectrum of action in premenstrual syndrome.
    Menkes DB; Taghavi E; Mason PA; Howard RC
    Int Clin Psychopharmacol; 1993; 8(2):95-102. PubMed ID: 8345163
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fluoxetine in the treatment of premenstrual dysphoric disorder.
    Carr RR; Ensom MH
    Ann Pharmacother; 2002 Apr; 36(4):713-7. PubMed ID: 11918525
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Rapid response to fluoxetine in women with premenstrual dysphoric disorder.
    Steinberg EM; Cardoso GM; Martinez PE; Rubinow DR; Schmidt PJ
    Depress Anxiety; 2012 Jun; 29(6):531-40. PubMed ID: 22565858
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Review of fluoxetine and its clinical applications in premenstrual dysphoric disorder.
    Pearlstein T; Yonkers KA
    Expert Opin Pharmacother; 2002 Jul; 3(7):979-91. PubMed ID: 12083997
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intermittent fluoxetine dosing in the treatment of women with premenstrual dysphoria.
    Steiner M; Korzekwa M; Lamont J; Wilkins A
    Psychopharmacol Bull; 1997; 33(4):771-4. PubMed ID: 9493491
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Low doses of fluoxetine for the treatment of emotional premenstrual syndrome: a randomized double-blind, placebo-controlled, pilot study.
    Maranho MCMF; Guapo VG; de Rezende MG; Vieira CS; Brandão ML; Graeff FG; Lovick T; Del-Ben CM
    Psychoneuroendocrinology; 2023 Nov; 157():106360. PubMed ID: 37572412
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Histories of sexual abuse are associated with differential effects of clonidine on autonomic function in women with premenstrual dysphoric disorder.
    Bunevicius R; Hinderliter AL; Light KC; Leserman J; Pedersen CA; Girdler SS
    Biol Psychol; 2005 Jul; 69(3):281-96. PubMed ID: 15925031
    [TBL] [Abstract][Full Text] [Related]  

  • 19. 5α-Reductase Inhibition Prevents the Luteal Phase Increase in Plasma Allopregnanolone Levels and Mitigates Symptoms in Women with Premenstrual Dysphoric Disorder.
    Martinez PE; Rubinow DR; Nieman LK; Koziol DE; Morrow AL; Schiller CE; Cintron D; Thompson KD; Khine KK; Schmidt PJ
    Neuropsychopharmacology; 2016 Mar; 41(4):1093-102. PubMed ID: 26272051
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fluoxetine versus Vitex agnus castus extract in the treatment of premenstrual dysphoric disorder.
    Atmaca M; Kumru S; Tezcan E
    Hum Psychopharmacol; 2003 Apr; 18(3):191-5. PubMed ID: 12672170
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.